1-((3S,4R)-3-((2-((1-ETHYL-1H-PYRAZOL-4-YL)AMINO)-7H-PYRROLO[2,3-D]PYRIMIDINI-4-YL)OXY)-4-FLUOROPIPERIDIN-1-YL)PROP-2-EN-1-ONE TARTRATE SALT, CRYSTAL FORM THEREOF, AND METHOD FOR ITS PREPARATION
PE0014862026A1Pending Publication Date: 2026-07-22DAEWOONG PHARM CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PE2026001800
- Authority / Receiving Office
- PE · PE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-05
- Filing Date
- 2024-12-05
- Publication Date
- 2026-07-22
Abstract
It refers to a tartrate salt of 1-((3S,4R)-3-((2-((1-ethyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)-4-fluoropiperidin-1-yl)prop-2-en-1-one, a crystalline form thereof, and a method for its preparation. It also refers to a pharmaceutical composition for preventing or treating inflammatory diseases, autoimmune diseases, proliferative diseases, among others.
Need to check novelty before this filing date? Find Prior Art